TRAITEMENT DES MALADIES ASSOCIÉES À L'HOMOLOGUE DU DELTA-LIKE 1 (DLK1) PAR INHIBITION DU TRANSCRIT ANTISENS NATUREL DE DLK1

• 收藏
• 分享

专利权人:

CuRNA; Inc.

发明人:

申请号：

EP10753955.3

公开号：

EP2408920B1

申请日:

2010.03.16

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Delta-like (1) homolog (DLK1), in particular, by targeting natural antisense polynucleotides of Delta-like (1) homolog (DLK1). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of (DLK1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/